Affordable Access

deepdyve-link deepdyve-link
Publisher Website

A phase 2 study of pemetrexed plus gemcitabine every 2 weeks for patients with recurrent or metastatic head and neck squamous cell cancer.

Authors
Type
Published Article
Journal
Cancer
Publication Date
Volume
117
Issue
4
Pages
795–801
Identifiers
DOI: 10.1002/cncr.25464
PMID: 20922785
Source
Medline

Abstract

Statistics

Seen <100 times